Cytokine suppression: the numbers The specific cytokines reduced by GLP-1 receptor activation read like a hit list of autoimmune mediators: TNF-alpha drives joint destruction in rheumatoid arthritis , skin plaque formation in psoriasis, and intestinal inflammation in Crohn disease
A year later, a team led by Graeme Bell at Chiron Corporation in California cloned and sequenced the versions found in humans and other mammals, which they dubbed GLP-1 and GLP-2, for glucagon-like peptides
Published MT-II literature often frames the compound through cyclic peptide structure, melanocortin receptor activity, and analog design [6] [13]
Semaglutide (approved 2017) features 94% amino acid homology to native GLP-1, allowing prolonged receptor activation and once-weekly dosing
[DOI] [PubMed] [Google Scholar] 60.Thulesen J, Hartmann B, rskov C, Jeppesen PB, Holst JJ, Poulsen SS